Claro Advisors LLC Gilead Sciences, Inc. Transaction History

Claro Advisors LLC

  • $540 Million
  • Q1 2024

A detailed history of Claro Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Claro Advisors LLC holds 6,994 shares of GILD stock, worth $466,429. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,994
Previous 7,670 8.81%
Holding current value
$466,429
Previous $621,000 17.55%
% of portfolio
0.09%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024
SELL
$71.58 - $87.29 $48,388 - $59,008
-676 Reduced 8.81%
6,994 $512,000
Q4 2023

Jan 22, 2024
SELL
$73.27 - $83.09 $40,957 - $46,447
-559 Reduced 6.79%
7,670 $621,000
Q3 2023

Oct 10, 2023
SELL
$73.94 - $80.67 $143,295 - $156,338
-1,938 Reduced 19.06%
8,229 $616,000
Q2 2023

Aug 08, 2023
BUY
$76.01 - $86.7 $167,298 - $190,826
2,201 Added 27.63%
10,167 $783,000
Q1 2023

Apr 17, 2023
BUY
$77.31 - $88.08 $214,921 - $244,862
2,780 Added 53.61%
7,966 $660,000
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $52,286 - $75,065
-839 Reduced 13.93%
5,186 $445,000
Q2 2022

Aug 12, 2022
BUY
$57.72 - $65.01 $38,730 - $43,621
671 Added 12.53%
6,025 $372,000
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $1,102 - $1,251
17 Added 0.32%
5,354 $389,000
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $17,125 - $18,476
253 Added 4.98%
5,337 $373,000
Q2 2021

Aug 13, 2021
SELL
$63.47 - $69.35 $952 - $1,040
-15 Reduced 0.29%
5,084 $350,000
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $20,340 - $23,207
339 Added 7.12%
5,099 $330,000
Q4 2020

Feb 12, 2021
SELL
$56.65 - $64.55 $226 - $258
-4 Reduced 0.08%
4,760 $277,000
Q3 2020

Nov 16, 2020
SELL
$62.1 - $78.08 $34,030 - $42,787
-548 Reduced 10.32%
4,764 $301,000
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $5,280 - $6,132
-73 Reduced 1.36%
5,312 $409,000
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $29,686 - $38,024
-474 Reduced 8.09%
5,385 $403,000
Q4 2019

Feb 14, 2020
SELL
$61.62 - $67.78 $25,202 - $27,722
-409 Reduced 6.53%
5,859 $381,000
Q3 2019

Oct 29, 2019
BUY
$62.51 - $69.0 $13,502 - $14,904
216 Added 3.57%
6,268 $397,000
Q2 2019

Jul 24, 2019
SELL
$61.87 - $69.38 $16,890 - $18,940
-273 Reduced 4.32%
6,052 $409,000
Q1 2019

May 10, 2019
SELL
$62.53 - $70.05 $23,948 - $26,829
-383 Reduced 5.71%
6,325 $411,000
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $406,102 - $529,932
6,708 New
6,708 $518,000

Others Institutions Holding GILD

# of Institutions
1,885
Shares Held
1B
Call Options Held
8.71M
Put Options Held
8.02M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email